Ventilatory response during CO2 inhalation after airway anesthesia with lidocaine.
Airway anesthesia with inhaled aerosolized lidocaine has been associated with increases in minute ventilation (VE) and mean inspiratory flow rate (VT/TI) during CO2 inhalation. However, it is unclear whether these increases are local effects of the anesthesia or systemic effects of absorbed and circulating lidocaine. To evaluate this 20 normal subjects were treated on separate days with aerosolized lidocaine, intravenous lidocaine, aerosolized control solution, or intravenous control solution, and the effects of each treatment on VE and VT/TI were determined and compared during room-air breathing and inhalation of 5% CO2-95% O2. None of the treatments altered VE or VT/TI during room-air breathing. Aerosolized lidocaine produced small (5.9-6.0%) increases in VE and VT/TI during CO2 inhalation, but these effects were not present after intravenous lidocaine despite equivalent lidocaine blood levels. We concluded that the increases in VE and VT/TI after aerosolized lidocaine were local effects of airway anesthesia rather than systemic effects of absorbed and circulating lidocaine.
D000328:Adult; D000336:Aerosols; D000772:Anesthesia, Local; D002245:Carbon Dioxide / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007700:Kinetics; D008012:Lidocaine / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D012119:Respiration / Q000187:drug effects*; D012143:Respiratory Physiological Phenomena; D012137:Respiratory System / Q000187:drug effects
D000336:Aerosols; D002245:Carbon Dioxide; D008012:Lidocaine